Clinical trials for the AstraZeneca vaccine resume
Clinical trials of the coronavirus vaccine by AstraZeneca and the University of Oxford have resumed.
The “green light” was given by the British Health Regulatory Authority, noting that it was now safe for the tests to proceed, the company announced on Saturday.
It is recalled that on Tuesday the company had announced the suspension of the tests, as one of the volunteers who took part had a serious side effect.
Saturday’s statement from AstraZeneca said the independent U.K. investigation into the event has concluded and it advised the Medicines Health Regulatory Authority, Britain’s equivalent of the Food and Drug Administration, that it was safe to resume the trial. The MHRA concurred and gave the green light for the trial to restart.
“The Company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic,” the spokesperson, Michele Meixell, wrote in an email.
You may be interested
The first Aegean Hawk S-70 helicopter was delivered to the Hellenic Navy by AeroservicesPanos - May 07, 2021
The first upgraded Aegean Hawk S-70 helicopter was delivered to the Hellenic Navy today, Thursday 6 May. The work on…
Foreigners looking to buy Greek property amid Covid-19 pandemicPanos - May 07, 2021
Despite the pandemic, the demand for a permanent holiday home in selected destinations in Greece by foreigners is on the…
Greek Taxisnet services not available for citizens over weekendPanos - May 07, 2021
Online services on the Taxisnet platform system will not be available to taxpayers over the weekend due to scheduled upgrading.…